Tracking the BIS expected move helps you see how far ProShares UltraShort Nasdaq Biotechnology -2x Shares's options market is pricing the stock to travel over a given period — whether that's the next day, week, or earnings cycle. ProShares UltraShort Nasdaq Biotechnology -2x Shares's expected move is derived directly from option premiums and gives you an objective range to plan trades, set strikes, and manage risk. Use our scanner to monitor the BIS expected move for this week's options, in real time.
The expected move is typically calculated from at-the-money straddle prices (or a blend of straddles and strangles) and represents roughly a one-standard-deviation range over the chosen timeframe. For BIS, comparing the implied expected move to actual realized moves over similar windows tells you whether the options market has historically overestimated or underestimated volatility. The BIS expected move for this week's options pricing is especially useful for short-dated traders, earnings players, and anyone selling premium who needs to know where the market thinks ProShares UltraShort Nasdaq Biotechnology -2x Shares is unlikely to go.
ProShares UltraShort Nasdaq Biotechnology seeks daily investment results, before fees and expenses, that correspond to two times the inverse (-2x) of the daily performance of the Nasdaq Biotechnology Index.
Iron condors, weekly premium sales, directional swing trades — they all live or die by where the market thinks the stock won't go. Our scanner tracks the BIS expected move across every expiration, benchmarks it against realized moves, and shows you when implied ranges are out of line with history. The ProShares UltraShort Nasdaq Biotechnology -2x Shares expected move for this week's options is the fastest read on short-term risk, which gives you a quick way to interpret what the options market thinks about BIS.
